Clinical Trial Update: Ketamine for Suicidality in Bipolar Depression [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating ketamine for suicidality in bipolar depression; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Bipolar Disorder, Major Depressive Episode | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-06